Market Introduction
Vitrectomy is a surgical procedure employed to treat various problems with the retina and vitreous and remove the vitreous gel from the eye. It is performed during retinal detachment with vitreous hemorrhage. As a result, this smoothens the procedure and prevents any further detachment of the retina. In addition, it is helpful for various repairs, such as the removal of scar tissue. It helps restore the vision loss caused due to vitreous humor bleeding.
Moreover, the significant advancements related to vitreoretinal surgery devices are expected to bolster the market growth during the forecast period. However, complications associated with vitrectomy limit the growth of the North America vitrectomy devices market.
The COVID-19 pandemic has created technological shifts crucial to providing better care. Due to coronavirus spreading, many cities were shut down, causing treatments and doctors/surgeons meeting cancellations. The patients suffering from critical surgeries such as neurosurgery, spinal surgery, ocular surgery, and ENT surgery require physical awareness and need to implement procedures in the clinics. For Instance: As of March 15, 2020, a total of 52, 923 patients were on the waitlist in the province of Ontario awaiting ophthalmic surgery. The number of non-emergency surgeries performed in the province decreased by 45-98% from March to May 2020, and 48-80% from April to May 2021 compared to the same months in 2019. Since the Coronavirus outbreak reached a pandemic status, the entire North America supply chain has been affected, commencing logistic capabilities and production capacity disruption. Therefore, COVID-19 had a substantial negative impact on the Vitrectomy devices market.
Market Overview and Dynamics
The North America vitrectomy devices market is expected to reach US$ 780.3 million by 2028 from US$ 490.8 million in 2021. The market is estimated to grow at a CAGR of 6.8% from 2021–2028. The rising demand for cataract, refractive, and vitrectomy surgeries is expected to increase the sales of vitrectomy devices. Leading market players are increasing their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets are expected to offer potential growth opportunities for key vitrectomy device manufacturers in the years to come. This can be attributed to the large patient population, high prevalence of eye diseases, such as cataracts and other vision impairments, increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries. High investments in life science and health research in emerging countries play a key role in upgrading the latest technologies in these countries. This factor, in turn, supports the inclination toward vitrectomy surgeries.
Key Market Segments
In terms of product, the vitrectomy machines segment accounted for the largest share of the North America vitrectomy devices market in 2020. In terms of patient type, the geriatric segment accounted for the largest share of the North America vitrectomy devices market in 2020. In terms of surgery approach, the posterior/pars plana vitrectomy segment accounted for the largest share of the North America vitrectomy devices market in 2020. In terms of application, the diabetic retinopathy segment accounted for the largest share of the North America vitrectomy devices market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the North America vitrectomy devices market in 2020. In terms of distribution channel, the retail sales segment accounted for the largest share of the North America vitrectomy devices market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the vitrectomy devices market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are D.O.R.C Dutch Ophthalmic Research Center (International)B. V, HOYA Corporation, NIDEK CO., LTD, Danaher (Leica Microsystems AG), Carl Zeiss Meditec, Alcon Inc., Iridex Corporation, Bausch Health Companies Inc., Topcon Corporation, and Optos.
Reasons to Buy Report
NORTH AMERICA VITRECTOMY DEVICES MARKET SEGMENTATION
By Product
By Surgery Approach
By Application
By End User
By Distribution Channel
By Country
Companies Mentioned
Strategic insights for the North America Vitrectomy Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 490.8 Million |
Market Size by 2028 | US$ 780.3 Million |
Global CAGR (2021 - 2028) | 6.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Vitrectomy Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The North America Vitrectomy Devices Market is valued at US$ 490.8 Million in 2021, it is projected to reach US$ 780.3 Million by 2028.
As per our report North America Vitrectomy Devices Market, the market size is valued at US$ 490.8 Million in 2021, projecting it to reach US$ 780.3 Million by 2028. This translates to a CAGR of approximately 6.8% during the forecast period.
The North America Vitrectomy Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Vitrectomy Devices Market report:
The North America Vitrectomy Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Vitrectomy Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Vitrectomy Devices Market value chain can benefit from the information contained in a comprehensive market report.